Abstract
HIG2 (hypoxia-inducible gene 2) is a biomarker of hypoxia and elevated in several cancers. Here, we show that HIG2 also upregulated HIF-1α expression under hypoxic conditions and enhanced AP-1 expression under normoxic conditions, which affects colorectal cancer cell survival. Importantly, over-expression of HIG2 promoted tumor growth by suppressing apoptosis in a mouse orthotopic model. These results are likely relevant to human disease since we found that the expression of HIG2 is gradually elevated as tumors progress. Collectively, these findings suggest that HIG2 plays an important role in promoting colorectal cancer growth in hypoxia-dependent and independent manners.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 159-165 |
| Number of pages | 7 |
| Journal | Cancer Letters |
| Volume | 341 |
| Issue number | 2 |
| DOIs | |
| State | Published - Dec 1 2013 |
Keywords
- Colorectal cancer
- HIF-1α
- HIG2
- Hypoxia
- Normoxia
- Survival
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways'. Together they form a unique fingerprint.
Cite this
Kim, S. H., Wang, D., Park, Y. Y., Katoh, H., Margalit, O., Sheffer, M., Wu, H., Holla, V. R., Lee, J. S., & DuBois, R. N. (2013). HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Cancer Letters, 341(2), 159-165. https://doi.org/10.1016/j.canlet.2013.07.028